Abstract Award Winners

 Top Scoring Abstract Award - $1,500 USD

The Top Scoring Abstract Award recognizes outstanding abstract submissions across the field of cell and gene therapy translation. This award is given to the abstract receiving the top score through our blinded-review process.

Abstract 11
Development and Clinical Validation of a Less Than 1 Day CAR-T Manufacturing Process

 Early Stage Professionals Awards - $1,000 USD

The Early Stage Professionals Awards recognize outstanding research submitted by Early Stage Professionals.

Abstract 10
Successful Redirection of TCR Specificity Against Cryptic Leukemia Antigens Using Non-viral TCR Engineering

Caroline Rulleau Hared, MSc
University of Montreal and Maisonneuve-Rosemont Hospital Research Center
Canada

Abstract 9
Engineering Relapse-Resistant CAR T-Cells for Blood Cancers (Penta T-Cells)

Philipp C. Rommel, Dr. rer. nat.
University of Pennsylvania
United States

Abstract 605
Improved Understanding of Cell Fate Using a Kidney Normothermic Machine Perfusion Model

Madison Niamh Cooper, BSc
Newcastle University
United Kingdom

 Technologist Awards - $1,000 USD

ISCT recognizes that research and innovation begins at "the bench" and have established the Technologist Awards to celebrate impactful submissions from laboratory technicians.

Abstract 939
Anti-tumor efficacy of Bi-specific antibody complexed gamma delta T cells against multiple myeloma

Seung Joo Hyun, PhD
ViGenCell Inc.
South Korea

Abstract 6
CellKine: A Single-Arm, Open-Label Phase I Clinical Trial Evaluating the Safety and Feasibility of Allogeneic Bone Marrow MSCs for Painful Lumbar Facet Arthropathy

Dan Yan, BSE
Mayo Clinic
United States

Abstract 18
Perfusion-powered production of over 100 CAR-T doses in a 2-litre stirred-tank bioreactor with automated product harvest, wash and concentration

Pierre Springuel, MSc
University College London
United Kingdom

 Top Scoring Emerging Economies Abstract Award - $1,000 USD

The Emerging Economy Abstract Award is granted to the top scoring abstract being presented by an author residing in a developing economy.

Abstract 987
Whole-Blood-Derived Donor Lymphocyte Infusion: A Game-Changer for Managing Chimerism Decline in Resource-Limited Settings

Divya Setya, MBBS, DNB
Yashoda Super Speciality Hospital
India

 Top Scoring Asia Abstract Award - $1,000 USD

Recognizes the highest scoring abstract submitted by a presenter residing in Asia. 

Abstract 8
Development of equitable access model for nationwide implementation of affordable CAR-T cell therapy in India: a real-world experience.

Ankit Banik, MSc
IIT Bombay
India

 Top Scoring South & Central America Abstract Award - $1,000 USD

The Top Scoring South & Central America Abstract Award recognizes outstanding contributions in CGT research within the South and Central America region. This award serves as a platform to acknowledge and promote the exceptional work of individuals who are making noteworthy strides within the dynamic landscapes of the South and Central America region.

Abstract 992
Optimized generation and expansion of functionally stable thymic and induced FoxP3+ Tregs cells
as potential immunotherapeutic tools in solid organ transplantation

Gloria Soldevila, PhD
Universidad Nacional Autónoma de México
Mexico

 NEW Top Scoring Europe Abstract Award - $1,000 USD

Recognizes the highest scoring abstract submitted by a presenter residing in Europe.

Abstract 48
Mass Scale Liver Organoid Expansion in an Automated Bioreactor Moving Towards Clinical Viable Numbers for Cell Therapy

Juda-El Jno Baptiste-Sam, MSc
Scinus Cell Expansion Netherlands B.V
Netherlands

 NEW Top Scoring Australia & New Zealand Abstract Award - $1,000 USD

Recognizes the highest scoring abstract submitted by a presenter residing in Australia or New Zealand. 

Abstract 949
Carboplatin Enhances Response to Car T Cell Therapy Through Macrophage Recruitment and Polarisation in Solid Tumors

Weronika Kulakowska, MSc
Monash University
Australia

 Host Region (US East; Central; West) Abstract Awards - $1,000 USD

 

Abstract 62
Circumventing Pediatric Solid Tumor Microenvironment Resistance by Combinatorial CAR NK and Immunomodulating Therapy

Wen Luo, PhD
New York Medical College
United States - East

---

Abstract 7
Impact of Age and acute GVHD on Thymic Reconstitution Post-HCT: Insights from Multicenter Immune Monitoring of Pediatric and Young Adult Patients

Devin McAvoy, MS
Memorial Sloan Kettering Cancer Center
United States - East

---

Abstract 65
The Future of Distributed Manufacturing: Rapid Production and Release of CAR-T on a Microfluidic Chip

Tugce Irem Pasa, MD
Mayo Clinic
United States - Central

---

Abstract 600
Large Scale Production of MSC-Derived Adipose Organoids for Wound Healing Applications

James A. Ankrum, PhD
University of Iowa
United States - Central

---

Abstract 3
Interim Results of a "First-in-Human" Phase 1 Clinical Study of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous, Wnt-Activated, Adipose-Derived Stem Cells in Participants with Mild to Moderate Alzheimer’s Disease

Christopher Duma, MD, FACS
Regeneration Biomedical, Inc.
United States - West

---

Abstract 606
Investigating the Impact of Piezo1 Deletion in Smooth Muscle Cells on Intestinal Function

Mireya Cruz, AA
California State University, Northridge
United States - West

Abstract 66
From Donor to Therapy: How Robust Manufacturing Shapes the TCR repertoire and Cytotoxic Power of Donor-Derived Allogeneic ex vivo Expanded and Activated γδ T Cell Products

Mariska A. ter Haak, BSc, ing.
IN8bio, Inc.
United States - East

---

Abstract 47
Breakthroughs in 3D printing: functional human islets in an alginate-dECM bioink

Quentin Perrier, PharmD, PhD
Wake Forest Institute for Regenerative Medicine
United States - East

---

Abstract 611
Gonadal mouse fat pad as an alternative site for islets transplantation without any encapsulation materials

Amar Yeware, PhD
University of Wisconsin-Madison
United States - Central

---

Abstract 956
Multiparametric cell isolation strategy supporting the GMP manufacture of Regulatory T-Cells

Kim Lueck, BS
Mayo Clinic Minnesota
United States - Central

---

Abstract 67
Development of a Protocol and Machine Learning Algorithms for the Derivation of Autologous Human iPSC on an Automated Platform to Enable Clinical Semi-autonomous Manufacturing

William Shahid Ansari, PhD
Aspen Neuroscience
United States - West

---

Abstract 952
Thymic Regulatory NK Cells: A Therapeutic Target for Restoring Immune Balance in Chronic Graft-Versus-Host Disease (cGVHD).

Madeline Lauener, PhD
City of Hope National Medical Center
United States - West

 iPSC Abstract Awards - $500–$1,000 USD

The iPSC Abstract Awards are designed to recognize outstanding abstracts related to induced Pluripotent Stem Cells (iPSC) research. iPSCs have emerged as an area of immense potential in disease modeling, drug discovery, and therapeutics, and this award aims to highlight and support innovative contributions in this growing clinical field.

Abstract 68
Generation of HLA-DR+CD1c-CD14-XCR1+ dendritic cells expressing CAR from induced pluripotent cells as an alternative treatment for cancer

Samuel Campanelli Freitas Couto, PhD
Fundação Pró-sangue
Brazil

Abstract 1229
Efficient Non-Invasive Delivery of RNA for Somatic Reprogramming of Blood-derived cells

Colleen Richards, MSc
Thermo Fisher Scientific in collaboration with Avectas
United States

Abstract 69
The Immunosurveillance of Hypoimmunogenic iPSC-Derived Pancreatic Islets: Impact of Viral Infections

Gabriel Siracusano, PhD
Vita-Salute San Raffaele University
Italy

 Stem Cell Engineering Abstract Awards - $500–$1,000 USD

The Stem Cell Engineering Abstract Awards aim to recognize outstanding contributions in the field of stem cell engineering. These awards are designed to highlight innovative and impactful research in the application of engineering principles to the study, manipulation, and application of stem cells. The awarded abstracts should demonstrate significant advancements, novel approaches, or breakthroughs that contribute to the progress of stem cell research and its applications.

Abstract 33
Correction of Gaucher disease type 1 by Genome-edited hematopoietic stem cells using novel mouse model

Luisa Natalia Pimentel Vera, PhD
Stanford University
United States

Abstract 34
Hematopoietic Stem/Progenitor Cell-Based Therapy for the Treatment of Angiogenic Deficiency in Diabetic Foot Ulcers: Engineering a Novel, Pericyte-Based Cell Sheet.

Andrea Rampin, PhD
IRCCS MultiMedica
Italy

Abstract 32
Results of the Phase I/IIb EXCELLENT trial evaluating the safety and efficacy of transendocardial injection of expanded autologous CD34+ cells in patients with recent myocardial infarction

Ibon Garitaonandia, PhD, MBA
CellProthera
France

 NEW Top Scoring Emerging Immunotherapy Abstract Awards - $500–$1,000 USD

The Top Scoring Emerging Immunotherapy Abstract Awards recognizes the latest immunotherapy research. This award is designed to support and promote advancements in the translation of novel immunotherapies, with the goal of bringing these new technologies from bench to bedside.

 NEW Top Scoring Exosomes Abstract Awards - $500–$1,000 USD

The Top Scoring Exosome Abstract Awards are designed to recognize outstanding abstracts related to Exosomes/Extracellular Vesicles (EVs) research. Exosomes have emerged as an area of immense potential for their applications in immune modulation, control of lymphocyte proliferation and many other therapeutic uses. This award aims to highlight and support innovative contributions in this growing clinical field.

 NEW Top Scoring Start-Up Abstract Awards - $1,000 USD

Enabler: The highest scoring abstract submitted by a young, emerging “Start-Up” company pursuing an innovative technology solution that will disrupt the sector’s current practices. This award recognizes groundbreaking ideas that demonstrate both ingenuity and potential for significant impact, driving progress and setting new standards within the industry. The winning submission will embody forward-thinking approaches that challenge traditional methods, offering a transformative vision for the future of the sector.

Therapeutic: The highest scoring abstract submitted by a young, emerging “Start-Up” company pursuing therapeutic product with clinical potential. The winning submission will exemplify breakthrough thinking and a commitment to advancing new treatments that address unmet medical needs, with a clear pathway toward clinical application and patient benefit.

 NEW Top Scoring Artificial Intelligence & Machine Learning Abstract Award - $1,000 USD

The highest scoring abstract in Artificial Intelligence & Machine Learning for Cell and Gene Therapy recognizes pioneering research that leverages AI/ML to advance the field of cell and gene therapies. This award is designed to support and promote innovations in AI/ML-driven methodologies that enhance the precision, scalability, and effectiveness of cell and gene therapies.